Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis
Theresa Benezeder, Clemens Painsi, VijayKumar Patra, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Revolutionizing Psoriasis Topical Treatment: Enhanced Efficacy Through Ceramide/Phospholipid Composite Cerosomes Co-Delivery of Cyclosporine and Dithranol: In-Vitro, Ex-Vivo, and in-Vivo Studies
Sammar Fathy Elhabal, Nashwa Abdelaal, Saeed A. S. Al-Zuhairy, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1163-1187
Open Access | Times Cited: 15
IL-1 Family Antagonists in Mouse and Human Skin Inflammation
Praxedis Martin, Jérémie D. Goldstein, Loïc Mermoud, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 61
Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions
Kacey L. Sachen, C Greving, Jennifer E. Towne
Cytokine (2022) Vol. 156, pp. 155897-155897
Open Access | Times Cited: 60
Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects
Ummu Umaimah Mohd Nordin, Noraini Ahmad, Norazlinaliza Salim, et al.
RSC Advances (2021) Vol. 11, Iss. 46, pp. 29080-29101
Open Access | Times Cited: 55
Microneedles as a momentous platform for psoriasis therapy and diagnosis: A state-of-the-art review
B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Umme Hani, et al.
International Journal of Pharmaceutics (2023) Vol. 632, pp. 122591-122591
Closed Access | Times Cited: 34
An updated guide in the management of psoriasis for every practitioner
Teodora-Larisa Timiș, Ioan Alexandru Florian, Ștefan Cristian Vesa, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 8
Open Access | Times Cited: 40
Breakthroughs and bottlenecks of psoriasis therapy: Emerging trends and advances in lipid based nano-drug delivery platforms for dermal and transdermal drug delivery
Siddharth Singh, Rajendra Awasthi
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104548-104548
Closed Access | Times Cited: 19
The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis
Kajetan Kiełbowski, Wiktoria Stańska, Estera Bakinowska, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3640-3675
Open Access | Times Cited: 6
Conditioned medium-enriched umbilical cord mesenchymal stem cells: a potential therapeutic strategy for spinal cord injury, unveiling transcriptomic and secretomic insights
Rajasekaran Subbarayan, Murugan Dinesh, S. Thirupathi Kumara Raja, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 5
Principles of Topical Therapy
D.A. Buckley
(2024), pp. 1-56
Closed Access | Times Cited: 4
Outline of Therapeutic Potential of Different Plants Reported Against Psoriasis via In Vitro, Pre‐Clinical or Clinical Studies
Pawan Gupta, Sudhakar Kalvatala, Abhinav Joseph, et al.
Phytotherapy Research (2025)
Closed Access
SUMOylation of TRIM28 is positively modulated by the BTB/POZ domain of Kaiso
Yaroslava Lobanova, Alexander M. Mazur, Daria Kaplun, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Investigation of the participation of the TRPV1 receptor in the irritant effect of dithranol in mice
Ana Merian da Silva, Marcella de Amorim Ferreira, Roberta Giusti Schran, et al.
European Journal of Pharmacology (2025), pp. 177291-177291
Closed Access
Pathology and Treatment of Psoriasis Using Nanoformulations
Divya Thirumal, Rakesh K. Sindhu, Shuchi Goyal, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1589-1589
Open Access | Times Cited: 11
Novel archetype in psoriasis management bridging molecular dynamics in exploring novel therapies
Krishna Yadav, Deependra Singh, Manju Rawat Singh
European Journal of Pharmacology (2021) Vol. 907, pp. 174254-174254
Closed Access | Times Cited: 23
Single‐cell transcriptome analysis reveals keratinocyte subpopulations contributing to psoriasis in corneum and granular layer
Qianya Zhao, Yan Wu, Xianwei Wu, et al.
Skin Research and Technology (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 3
Mast cells express IL17A, IL17F and RORC, are activated and persist with IL-17 production in resolved skin of patients with chronic plaque-type psoriasis
Theresa Benezeder, Natalie Bordag, Johannes Nikolaus Woltsche, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 3
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
Robert Ramer, Burkhard Hinz
Cells (2022) Vol. 11, Iss. 24, pp. 4102-4102
Open Access | Times Cited: 14
Rh family C glycoprotein contributes to psoriatic inflammation through regulating the dysdifferentiation and cytokine secretion of keratinocytes
Wei Liu, Yaqi Wang, Yitian Zhang, et al.
Journal of Dermatological Science (2024) Vol. 114, Iss. 1, pp. 2-12
Closed Access | Times Cited: 1
NETs contribute to psoriasiform skin inflammation: a novel therapeutic approach targeting IL-36 cytokines by a small molecule tetrahydroxystilbene glucoside
Zi‐Ying Zhan, Min Jiang, Zhihong Zhang, et al.
Phytomedicine (2024) Vol. 131, pp. 155783-155783
Closed Access | Times Cited: 1
Novel Dithranol Loaded Cyclodextrin Nanosponges for Augmentation of Solubility, Photostability and Cytocompatibility
Sunil Kumar, Rekha Rao
Current Nanoscience (2021) Vol. 17, Iss. 5, pp. 747-761
Closed Access | Times Cited: 11
IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis
Scott A. Ochsner, Mesias Pedroza, Rudolf Pillich, et al.
Journal of Investigative Dermatology (2023) Vol. 143, Iss. 9, pp. 1689-1699
Open Access | Times Cited: 4
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection
Ann‐Kathrin Hartmann, Joschka Bartneck, Jonas Pielenhofer, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Sericin-Based Poly(Vinyl) Alcohol Relieves Plaque and Epidermal Lesions in Psoriasis; a Chance for Dressing Development in a Specific Area
Khwanchanok Tuentam, Pornanong Aramwit, Onrapak Reamtong, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 145-145
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top